Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder

Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder

We have recently reported sex differences in the plasma concentrations of lysophosphatidic acid (LPA) and alterations in LPA species in patients with alcohol and cocaine use disorders. Preclinical evidence suggests a main role of lysophosphatidic acid (LPA) signaling in anxiogenic responses and drug...

Full description

Bibliographic Details
Main Authors:	Nerea Requena-Ocaña, María Flores-López, Nuria García-Marchena, Francisco J. Pavón-Morón, Carmen Pedraza, Agustín Wallace, Estela Castilla-Ortega, Fernando Rodríguez de Fonseca, Antonia Serrano, Pedro Araos
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	International Journal of Molecular Sciences
Subjects:	sex differences cocaine use disorder lysophosphatidic acid psychiatric comorbidity anxiety disorder attention-deficit/hyperactivity disorder
Online Access:	https://www.mdpi.com/1422-0067/24/21/15586

Similar Items

Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders
by: María Flores-López, et al.
Published: (2022-04-01)

Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease
by: María Flores-López, et al.
Published: (2021-09-01)

Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex
by: Nuria García-Marchena, et al.
Published: (2022-05-01)

Higher Impulsivity As a Distinctive Trait of Severe Cocaine Addiction among Individuals Treated for Cocaine or Alcohol Use Disorders
by: Nuria García-Marchena, et al.
Published: (2018-02-01)

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
by: Clemow DB, et al.
Published: (2017-02-01)

The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders
by: Simona Dedoni, et al.
Published: (2024-03-01)

A Retrospective Comparative Study in Patients With Cocaine Use Disorder Comorbid With Attention Deficit Hyperactivity Disorder Undergoing an rTMS Protocol Treatment
by: Stefano Cardullo, et al.
Published: (2021-03-01)

Comparison of serum vitamin D levels between healthy and ADHD children
by: Armon Massoodi, et al.
Published: (2023-09-01)

Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis
by: Rosa Maza-Quiroga, et al.
Published: (2017-10-01)

Associations Between Psychiatric Disorders and Enuresis in Taiwanese Children: A National Population-Based Study
by: Tsai HL, et al.
Published: (2020-02-01)

Cocaine Use Disorder (CUD): Current Clinical Perspectives
by: Schwartz EKC, et al.
Published: (2022-09-01)

Sociodemographic and clinical profile of crack cocaine treatment-seeking individuals living in “Crackland”, Brazil
by: André Q. C. Miguel, et al.
Published: (2022-02-01)

A preliminary evaluation of N-acetylcysteine's effects on patient adherence to treatment for cocaine use disorder
by: Jake Schechter, DNP, PMHNP-BC, RN, et al.
Published: (2023-03-01)

Assessment of cognitive functioning using the Mini Mental State Examination in men with alcohol and crack cocaine use disorder
by: Jaqueline B. Schuch, et al.
Published: (2023-08-01)

Severe rhabdomyolysis induced by cocaine contaminated with caffeine: a case report
by: Maria Monotya-Giraldo, et al.
Published: (2020-06-01)

Cocaine use disorder in females is associated with altered social decision-making: a study with the prisoner’s dilemma and the ultimatum game
by: Thiago Wendt Viola, et al.
Published: (2019-07-01)

Prevalence of adult attention deficit hyperactivity disorder in patients with bipolar affective disorder: A 1-year hospital-based cross-sectional study
by: Nitin Pattanshetti, et al.
Published: (2016-01-01)

Overcoming bashfulness: how cocaine aided Freud to summon the courage to meet Charcot
by: Hélio A. G. Teive, et al.
Published: (2019-12-01)

Fingertip and nasal tip thermal burn in crack cocaine user
by: Fred Bernardes Filho, et al.
Published: (2013-10-01)

Evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression
by: J.R. Gutiérrez Casares, et al.
Published: (2022-06-01)

Patient perspectives on current and potential therapies and clinical trial approaches for cocaine use disorder
by: Suzanne Maahs, et al.
Published: (2024-02-01)

The effect of religiosity during childhood and adolescence on drug consumption patterns in adults addicted to crack cocaine
by: Alexandre Rezende-Pinto, et al.
Published: (2018-09-01)

The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis
by: Nader Salari, et al.
Published: (2023-04-01)

Psychiatric disorders and somatic comorbidities
by: A. Kerkeni, et al.
Published: (2021-04-01)

Subarachnoid and intracerebral hemorrhage in cocaine abusers
by: Aleksić Ivan, et al.
Published: (2021-01-01)

I can’t wait! An investigation into time processing in cocaine use disorder
by: T. Burke, et al.
Published: (2022-06-01)

A Rat Model of Cocaine-Alcohol Polysubstance Use Reveals Altered Cocaine Seeking and Glutamate Levels in the Nucleus Accumbens
by: Bethany A. Stennett, et al.
Published: (2020-08-01)

Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
by: Jesús Herrera-Imbroda, et al.
Published: (2023-09-01)

Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder
by: Jesús Herrera-Imbroda, et al.
Published: (2023-05-01)

A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I1-Imidazoline Receptor)
by: Benjamin Keller, et al.
Published: (2017-12-01)

Commentary: Clinical Improvements in Comorbid Gambling/Cocaine Use Disorder (GD/CUD) Patients Undergoing Repetitive Transcranial Magnetic Stimulation (rTMS)
by: Hang Ou, et al.
Published: (2020-07-01)

Vldlr overexpression causes hyperactivity in rats
by: Iwata Keiko, et al.
Published: (2012-10-01)

Prevalence of suicide in cocaine users accessing health services: a systematic review and meta-analysis
by: Milton Moçambique, et al.
Published: (2022-06-01)

Biomarkers of Relapse in Cocaine Use Disorder: A Narrative Review
by: Margaux Poireau, et al.
Published: (2022-07-01)

Prepulse Inhibition in Cocaine Addiction and Dual Pathologies
by: Isis Gil-Miravet, et al.
Published: (2021-02-01)

Lifetime co-occurring psychiatric disorders in newly diagnosed adults with attention deficit hyperactivity disorder (ADHD) or/and autism spectrum disorder (ASD)
by: Artemios Pehlivanidis, et al.
Published: (2020-08-01)

Understanding the patient and supporter journey in cocaine use disorder
by: Denise Leclair, et al.
Published: (2024-04-01)

Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases
by: Shufan Jiang, et al.
Published: (2023-08-01)

Oral changes in cocaine abusers: an integrative review
by: César Antonio Araújo Melo, et al.
Published: (2022-07-01)

Impact of psychiatric comorbidity on the severity, short-term functional outcome, and psychiatric complications after acute stroke
by: Hoyer C, et al.
Published: (2019-07-01)